Over at PharmaGossip the following post was made on Saturday.

Define “gouging”

Prices on 64 drugs are expected to more than double this year, up from just 22 in 2004, according to researchers at the University of Minnesota.

Many of the drugs are used to treat rare ailments, such as Ovation Pharmaceuticals’ Cosmegen, which is prescribed exclusively to children with rare kidney cancer. The company raised the drugs’ price more than 3,400 percent in 2006 to $593.75 from just $16.79

I’d say Ovation Pharmaceuticals need a round of applause..

The original article was on MSNBC.

My only concern with the article is that Andy Borowitz uses researchers from the University of Minnesota extensively in his column.